Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $280829.0 as the latest value for Q1 2021.

  • Quarterly Total Non-Current Liabilities fell 13.8% to $280829.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $280829.0 through Mar 2021, down 13.8% year-over-year, with the annual reading at $608992.0 for FY2020, 77.65% up from the prior year.
  • Total Non-Current Liabilities for Q1 2021 was $280829.0 at ENDRA Life Sciences, down from $608992.0 in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $645450.0 in Q2 2020, with the low at $280829.0 in Q1 2021.
  • Average Total Non-Current Liabilities over 3 years is $455767.9, with a median of $358915.0 recorded in 2019.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 77.65% in 2020, then decreased 13.8% in 2021.
  • Over 3 years, Total Non-Current Liabilities stood at $342812.0 in 2019, then surged by 77.65% to $608992.0 in 2020, then crashed by 53.89% to $280829.0 in 2021.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $280829.0, $608992.0, and $627573.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.